Cassiopea SpA

Quick facts

Phase 3 pipeline

• CB-03-01 cream, 1% · Dermatology
  CB-03-01 is an androgen receptor antagonist that blocks the effects of androgens in the skin to reduce sebum production and inflammation associated with acne.
• Clascoterone 5% solution · Dermatology
  Clascoterone is an androgen receptor antagonist that blocks androgen signaling in skin to reduce sebum production and acne lesions.

Phase 2 pipeline

• cortexolone 17α-propionate

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Cassiopea SpA portfolio CI brief
• Cassiopea SpA pipeline updates RSS